Auspice Ltd 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 06:40 am Unchanged |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Auspice Ltd | 941,206 1.960% |
0 (Unchanged) |
Filing |
| 2023-02-09 06:15 am Sale |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Auspice Ltd | 941,206 1.960% |
-470,000 (-33.30%) |
Filing |
| 2022-04-06 10:27 am Purchase |
2022-04-06 | 13G | Terns Pharmaceuticals, Inc. TERN |
Auspice Ltd | 1,411,206 5.600% |
1,411,206 (New Position) |
Filing |